Keywords: daiichi, acquires, merck, serono, turkish, staff, subsidiary
Daiichi acquires Merck Serono Turkish staff
Article | 10 November 2008
The Turkish subsidiary of Japan's second-largest drugmaker, Daiichi Sankyo, has acquired 20 members of the cardio-metabolism sales force at Merck IL, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Elan makes "transformational" acquisitions and a divestment
